VERENAFUSP ALFA
UNII X7J5T5JKD6

Substance Identification & Data

This profile provides standardized clinical and technical data for Verenafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X7J5T5JKD6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2699034-69-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
X7J5T5JKD6
CAS Registry Number
2699034-69-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
VERENAFUSP ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211818
National Cancer Institute reference terminology for clinical and research data.
INN ID
12878
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Verenafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VERENAFUSP ALFA

Common Names & Synonyms

CHIMERIC IMMUNOGLOBULIN G1-KAPPA ANTIGEN-BINDING FRAGMENT (FAB) ANTI-(HUMAN INSULIN RECEPTOR (INSR)) FUSED AT THE C-TERMINUS OF THE HEAVY CHAIN VIA PEPTIDE LINKER 221LSS223 TO HUMAN IDURONATE-2-SULFATASE FRAGMENT, GLYCOFORM ALFA
GAMMA 1 HEAVY CHAIN (1-220) (VH (MUS MUSCULUS IGHV1S56*01 -(IGHD) -IGHJ3*01, CDR-KABAT (5.17.4) (31-35.50-66.99-102)) (1-113) -HOMO SAPIENS IGHG1*01 (CH1 (114-211), HINGE TRUNCATED REMOVING C-TERMINAL TCPPCP (212-220))) FUSED VIA PEPTIDE LINKER 221LSS223 TO HUMAN IDURONATE-2-SULFATASE (EC:3.1.6.13, ALPHA-LIDURONATE SULFATE SULFATASE (IDURSULFASE)) (224-748 IN THE CURRENT SEQUENCE, RESIDUE 282 POSTTRANSLATIONALLY MODIFIED TO FORMYLGLYCINE (FGLY)), (216-214') -DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV9-120*01 -IGKJ1*01, CDR-KABAT (11.7.9) (24'-34'.50'-56'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')); DIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA
VERENAFUSP ALFA [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus